Arkolith/Insider Trading/RNAC/Form 4

Springer Timothy A

Director, 10% OwnerCartesian Therapeutics, Inc. (RNAC) · full profile →Form 4 · filed Mar 20, 2025
Net Buying
Open-Market Buys
$1.4M
Open-Market Sells
$0
Net Open-Market Flow
$1.4M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 20, 2025Buy(P)55K$15.59$856K8.6M
Mar 19, 2025Buy(P)20K$14.97$303K8.6M
Mar 18, 2025Buy(P)15K$14.42$213K8.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001453687-25-000062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML